The pyrazolyl-urea GeGe3 inhibits tumor angiogenesis and reveals dystrophia myotonica protein Kinase (DMPK)1 as a novel angiogenesis target by Meta, Elda et al.
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The pyrazolyl-urea GeGe3 inhibits tumor angiogenesis and 




The following antibodies were used in this study for western blotting, immunoprecipitation or for immunofluorescence 
imaging:
Names Manufacturer Origin Reactivity
Primary antibodies
phospho-ERK1/2 (pERK1/2) WB:1/1000 Cell signaling Rabbit Human
ERK 1/2 WB:1/1000 Cell signaling Mouse Human
phospho-p38MAPK 
(pp38MAPK) WB:1/1000 Cell signaling Rabbit Human
p38MAPK WB/1/1000 Cell signaling Rabbit Human
phospho-AKT-T308 (pAKT) WB:1/4000 Cell signaling Rabbit Human
phospho-AKT-S473 (pAKT) WB:1/2000 Cell signaling Rabbit Human
AKT WB:1/2000 Cell signaling Rabbit Human
α-tubuline WB:1/4000 Millipore Mouse Human
Aurora C WB:1/500 Genetex Rabbit Human
Polo-like kinase 2 (PLK2) WB:1/500 Genetex Rabbit Human
DMPK WB:1/500, IF:1/100 Genetex Rabbit Human, mouse
DMPK WB:1/500 Biotechne Mouse Human
Phospho- threonine PTR-8 IP:5μg/ml SigmaAldrich Mouse Human
Phospho-serine PSR-45 IP:5μg/ml SigmaAldrich Mouse Human
Phospho-threonine 42H4 
IgM WB:1/1000 Cell signaling Mouse Human
VE-cadherin-FITC, REA199 IF:1/100 Miltenyi Biotech Human Human
REA Control (S)-FITC IF:1/100 Miltenyi Biotech Human none
CD31-Alexa Fluor 647, 
clone 390 IF:1/200 Biolegend Rat Mouse
a-SMA-biotin, 1A4, IgG2a IF:1/200 Skalli et al. Mouse Human, mouse
Actin WB:1/5000 Millipore Mouse Human
Phospho-CaMK1(Thr177) WB:1/1000 Thermofisher Rabbit Human
CaMK1 (H-8) WB:1/1000 Santa Cruz BT Mouse Human
Secondary antibodies
Anti-rabbit-HRP WB:1/10000 Jackson Imm. Goat Rabbit IgG
Anti-mouse-HRP WB:1/3000 Jackson Imm. Goat Mouse IgG
Anti-mouse IgM-HRP WB:1/3000 Jackson Imm. Donkey Mouse IgM
Anti-rabbit-AF488 IF:1/500 Jackson Imm. Donkey Rabbit IgG
Anti-rabbit-AF594 IF:1/500 Jackson Imm. Donkey Rabbit IgG
Anti-mouse IgG2a-AF594 IF:1/500 Jackson Imm. Donkey Mouse IgG2a
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PI cytotoxicity test by flow cytometry
HUVEC were seeded in 24-well plates at 30,000 
cells/well and cultured overnight. The next day cells 
were incubated with both VEGF (50 ng/ml) and GeGe3 
(20 μM) for 24-Hrs. Floating cells contained in culture 
supernatant were collected as well as adherent cells after 
detachment by trypsin treatment. Cells were centrifuged 
and re-suspended in PBS containing EDTA (2 mM) and 
BSA (0.5%). Propidium iodide (PI) at 1 μg/ml was added 
to the cells just before flow cytometry acquisition with a 
BD Accury™ C6. Data were analyzed with the BD Accury 
C6 Software and reported as percentage of dead cells with 
respect to the total cell number.
Serine/threonine kinase array assays
Confluent and starved HUVEC were stimulated with 
VEGF at 50 ng/ml for 10 min. Cells were lysed with the 
M-PER mammalian extraction buffer (Thermo Scientific) 
containing 1:50 Halt phosphatase inhibitor cocktail 
(Thermo Scientific) and 1:50 Halt protease inhibitor 
cocktail, EDTA-free (Thermo Scientific). The lysates were 
sonicated and centrifuged at 12000 g for 15 minutes to 
remove all debris. The supernatant was aliquoted, snap-
frozen in liquid nitrogen, and stored at –80°C until further 
processing. Protein concentration was determined with the 
MicroBCA™ Protein Assay Kit (Thermofisher).
All reagents and PamChip kinase arrays used 
in PamGene runs were purchased from PamGene 
International B.V. Sample incubation, detection, and 
analysis were performed in a PamStation12 according to 
the manufacturer’s instructions. Prior to incubation with 
the kinase reaction mix, the arrays were blocked with 2% 
BSA in water for 30 cycles to prevent non-specific binding 
and washed 3 times with protein kinase (PK) assay buffer. 
Kinase reaction was performed for 30 min with 1 μg of 
total protein extract, 20 μM of GeGe3 or DMSO, 400 
μM of ATP, PK buffer, BSA, STK antibody mix in 40 μL 
final volume/array. Phosphorylated peptides were detected 
with an anti-rabbit–FITC antibodies that recognizes a 
pool of anti–phospho serine/threonine antibodies, in a 1 
hour incubation following the PamGene STK workflow 
protocol. The experiment was performed in triplicate. The 
images obtained from the phosphorylated arrays were 
quantified using the BioNavigator software (PamGene 
International BV).
Histochemistry of treated mouse kidney
Mice were treated with either DMSO or GeGe3 
(2 mg/kg) every two days for a total of six days before 
sacrifice. Mouse kidneys were harvested, dehydrated and 
embedded in paraffin for cross-section. Cross-sections 
(10 per organ) of 3-μm of diameter were stained with 
hematoxylin and eosin as previously described in Sidibe 
et al [1]. Stained cross-sections were imaged by using 
the slide scanner Axio Scan.Z1 (Zeiss). High resolution 
images were stitched to have global overview of the whole 
organ.
REFERENCE
1. Sidibe, A. et al. VE-cadherin Y685F knock-in mouse is 
sensitive to vascular permeability in recurrent angiogenic 
organs. American journal of physiology. Heart and 
circulatory physiology 307, H455-463, https://doi.
org/10.1152/ajpheart.00774.2013(2014).
www.impactjournals.com/oncotarget/  Oncotarget, Supplementary Materials 2017
Supplementary Figure 1: Chemical structure of the pyrazolyl-urea GeGe3. GeGe3 is the Ethyl 1-(2-hydroxypentyl)-5-(3-(3-
(trifluoromethyl)phenyl)ureido)-1H-pyrazole-4-carboxylate.
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Supplementary Figure 2: Effect of GeGe3 on endothelial cell viability. (A) Analysis of the membrane integrity of HUVEC 
by flow cytometry. HUVEC were cultured with DMSO or GeGe3 for 24-Hrs. Floating and adherent cells were harvested and propidium 
iodide (PI) was added before acquisition by flow cytometry. Untreated HUVECs without PI were used as negative control. PI+ cells 
were quantified as apoptotic cells and used as an indicator of the compound toxicity. No difference was noticed between GeGe3- and 
DMSO-treated cells. (B) Morphology of HUVEC determined by the forward (FSC) and side (SSC) scatters by flow cytometry. HUVEC 
morphology was similar between DMSO and GeGe3 treatment.
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Supplementary Figure 3: Effect of VEGF and GeGe3 treatment on p38MAPK, ERK and AKT phosphorylation and 
protein levels. Kinetic effect of GeGe3 on VEGF-induced activation of p38MAPK, ERK and AKT. Confluent HUVECs were starved 
for at least 4 h. The cells were then incubated for 10-min with fresh medium containing GeGe3 or control DMSO and then VEGF (50 ng/
ml) was added for the different time periods shown. Finally protein extracts were analyzed for phosphorylation of p38MAPK, ERK1/2 
and AKT by Western blotting. The total protein levels of p38MAPK, ERK and AKT were analyzed as well as α-tubulin levels for protein 
loading controls. Whereas changes in kinases phosphorylations over time were observed, no change in kinase total protein levels was 
noticed. Data are representative of 3 independent kinetic experiments.
www.impactjournals.com/oncotarget/  Oncotarget, Supplementary Materials 2017
Supplementary Figure 4: Effect of VEGF and GeGe3 treatment on CaMK1 phosphorylation. Confluent HUVECs were 
starved for at least 4 hours. Next the cells were incubated for 10 min with fresh medium containing GeGe3 or control DMSO and then 
VEGF (50 ng/ml) was added for 5-min before protein extraction. Phosphorylated CaMK1 (P-CaMK1) was analyzed with a phophosite 
specific antibody targeting phospho-Threonine 177 of CaMK1. P-CaMK1 was normalized on β-actin levels used as loading control. Band 
intensity level is indicative of the phosphorylated form of CaMK1.
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Supplementary Figure 5: Effect of GeGe3 on DMPK expression and eventual toxicity in mouse kidney. (A) Morphological 
analysis of GeGe3 effect on mouse kidney. Kidneys from mice treated with DMSO or GeGe3 (2 mg/kg) for 6 days were embedded in 
paraffin and cross-sections were stained with hematoxin/eosin to stain nuclei and cytoplasm respectively. Sections were pictured with the 
slide scanner Axio Scan.Z1 (Zeiss) and images were stitched. The section overviews on the left (scale bar: 500 μm) show no morphological 
difference between DMSO and GeGe3 treated kidneys. High magnification on the right (scale bar: 50 μm) of red section area on the left 
show no difference in nephron morphology. Data are representative of 10 sections per organs from 6 mice per group. (B) Analysis of 
DMPK1 expression in kidney of mice treated with DMSO and GeGe3. Tubulin expression indicates protein loading. Expression of DMPK1 
in kidney was not affected by GeGe3 treatment.
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Supplementary Video 1: DMPK expression in LLC1 vasculature. Gray: DMPK, Green: CD31 (endothelial cells), Red: SMA 
(mural cells), Blue: DAPI (Nuclei).
See Supplementary Video 1
